Application‑based Vascular Probes segmentation reveals four dominant end‑use clusters that shape demand patterns and guide investment decisions. In cardiology, probes are employed for coronary artery assessment, fractional flow reserve measurement, and intravascular imaging, representing the largest slice of the market because of the high procedure volume and reimbursement rates. Interventional radiology utilizes flow and pressure probes to navigate complex arterial networks during embolization, tumor ablation, and stent placement, contributing a substantial share driven by the growth of image‑guided therapies. Vascular surgery relies on pressure and temperature probes for intra‑operative monitoring during bypass grafting and aneurysm repair, a segment that benefits from the aging population and rising incidence of peripheral vascular disease. Finally, peripheral artery disease diagnostics employ optical and flow sensors to evaluate limb perfusion, a niche yet rapidly expanding area supported by increased screening programs. The accompanying pie chart quantifies these four application segments as 35 % cardiology, 30 % interventional radiology, 20 % vascular surgery, and 15 % peripheral artery disease diagnostics, illustrating the current market taxonomy for Vascular Probes segmentation.
